ACUTAAS3,458.40

Acutaas Chemicals Ltd.

· Pharma & Health
₹ CrorePeersANURASAETHERBLUEJETCAPLIPOINTCONCORDBIOEMCUREJBCHEPHARMERISMcap ₹28,314 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt216.68.226.526.5
Net Debt186.9-177.0-189.1-189.1
Total Debt/Equity0.320.010.020.02
Net Debt/Equity0.27-0.13-0.11-0.11
Total Debt/EBITDA1.690.040.060.06
Net Debt/EBITDA1.45-0.76-0.39-0.35
Interest Coverage (EBIT/Interest)18.9333.04135.98135.98
Total Debt/Total Capital %24.090.621.521.52
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.